EUVIMEDEUVIMED entdecken
Crossref

Clinical outcomes by histologic pattern of early-stage metaplastic breast cancer: A single-institution retrospective study

Ashley Matusz-Fisher, Annabel Chen, Erin E Donahue, Courtney R Schepel, Michelle L Wallander, Chad A Livasy, Richard L White, Antoinette R Tan, Lejla Hadzikadic-Gusic

Clinical Breast Cancer · 2025-10 · 25 (7) · e935-e944

DOI: 10.1016/j.clbc.2025.04.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2025-10. Verfasst von Ashley Matusz-Fisher und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Solid Tumor Oncology and Investigational Therapeutics, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health Lev…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Breast Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Metaplastic breast cancer (MpBC) is a rare, aggressive type of breast cancer composed of several histologic patterns. This study evaluated outcomes among the MpBC histologic patterns, which include spindle cell/sarcomatous, squamous, heterologous mesenchymal, and mixed. PATIENTS AND METHODS: A retrospective chart review identified patients with early-stage MpBC diagnosed between January 1, 2010, and September 1, 2021. A matched control patient cohort with nonmetaplastic triple-negative breast cancer (TNBC) was selected. Associations between MpBC histologic patterns and disease characteristics were evaluated using chi-squared and Wilcoxon tests. Kaplan-Meier estimates and log rank tests assessed differences in recurrence-free survival (RFS) and overall survival (OS). RESULTS: In the MpBC cohort (n = 106), histologic patterns included spindle cell/sarcomatous (34%), squamous (16%), heterologous mesenchymal (31%), mixed (18%), and other (1%). In patients with MpBC who received neoadjuvant chemotherapy (n = 32), residual cancer burden (RCB) was not found to be significantly different between the spindle cell/sarcomatous pattern versus other patterns (P = .81). In the entire MpBC cohort, patients with the spindle cell/sarcomatous pattern had inferior RFS (P = .02) and OS (P = .004) compared to patients with other patterns. There was no significant difference in RFS (P = .90) or OS (P = .90) between the MpBC and TNBC cohort. CONCLUSION: RCB did not differ among the MpBC histologic patterns, but outcomes were inferior in patients with the spindle cell/sarcomatous pattern. Outcomes were also inferior in patients with MpBC receiving neoadjuvant versus adjuvant chemotherapy. Our study did not find a difference in outcomes between patients with MpBC versus nonmetaplastic TNBC. More investigation with larger sample sizes and biomarkers is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsBreast NeoplasmsNeoplasm Recurrence, LocalHumansFemaleRetrospective StudiesMiddle AgedAgedAdultNeoadjuvant TherapyNeoplasm StagingMetaplasiaPrognosisChemotherapy, AdjuvantSurvival RateFollow-Up StudiesBreastKaplan-Meier Estimate

Stichwörter der Autor:innen

Metaplastic carcinomaNeoadjuvant chemotherapyOverall survivalRecurrence-free survivalResidual cancer burden

Autor:innen und Institutionen

  • Department of Solid Tumor Oncology and Investigational Therapeutics, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health Levine Cancer, Wake Forest University School of Medicine, Charlotte, NC.
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Clinical Trials Office, Atrium Health Levine Cancer, Charlotte, NC.
  • Department of Biostatistics and Data Sciences, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health Levine Cancer, Charlotte, NC.
  • Department of Pathology, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health Levine Cancer, Charlotte, NC.
  • Division of Surgical Oncology, Department of Surgery, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health Levine Cancer, Wake Forest University School of Medicine, Charlotte, NC.
  • Division of Surgical Oncology, Department of Surgery, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health Levine Cancer, Wake Forest University School of Medicine, Charlotte, NC. Electronic addr…

Zitieren

APA

Matusz-Fisher, A., Chen, A., Donahue, E. E., Schepel, C. R., Wallander, M. L., Livasy, C. A., White, R. L., Tan, A. R., & Hadzikadic-Gusic, L. (2025). Clinical outcomes by histologic pattern of early-stage metaplastic breast cancer: A single-institution retrospective study. Clinical Breast Cancer, 25(7), e935-e944. https://doi.org/10.1016/j.clbc.2025.04.022

Vancouver

Matusz-Fisher A, Chen A, Donahue EE, Schepel CR, Wallander ML, Livasy CA, et al. Clinical outcomes by histologic pattern of early-stage metaplastic breast cancer: A single-institution retrospective study. Clinical Breast Cancer. 2025;25(7):e935-e944. doi:10.1016/j.clbc.2025.04.022

BibTeX
@article{MatuszFisher2025,
  author = {Matusz-Fisher, Ashley and Chen, Annabel and Donahue, Erin E and Schepel, Courtney R and Wallander, Michelle L and Livasy, Chad A and White, Richard L and Tan, Antoinette R and Hadzikadic-Gusic, Lejla},
  title = {Clinical outcomes by histologic pattern of early-stage metaplastic breast cancer: A single-institution retrospective study},
  journal = {Clinical Breast Cancer},
  year = {2025},
  volume = {25},
  number = {7},
  pages = {e935--e944},
  doi = {10.1016/j.clbc.2025.04.022}
}
Kostenlos starten →